IQ Capital investment portfolio

Baseimmune creates AI‑driven, computationally designed antigen therapeutics using advanced protein‑engineering techniques, delivering next‑generation active immunotherapies for chronic diseases. Its platform is marketed to pharmaceutical and biotech firms developing vaccines and immunotherapy

Boltzbit builds custom generative‑AI models that continuously learn from user data, branded as General Learning Intelligence (GLI) or AGI 2.0, and delivers these adaptive AI solutions to enterprise customers, notably in financial services, data‑intensive businesses and high‑growth technology sectors. It also provides AI research and integration services that enable organisations to own, train and control their own live‑learning models.